Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PV-10 Intralesional Injection vs Systemic Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma

NCT02288897 is registered in ClinicalTrials.gov with Provectus Biopharmaceuticals, Inc. as lead sponsor.

NCT NCT02288897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02288897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PV-10 Intralesional Injection vs Systemic Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma
Lead sponsor
Provectus Biopharmaceuticals, Inc.
Phase
Phase 3
Overall status
Terminated
Start date
April 30, 2015
Completion date
September 30, 2019
Enrollment
20 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous melanoma